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Human monocyte-derived dendritic cells (MoDC) have
both histamine H1 and H2 receptors and can induce
CD86 expression by histamine. Nevertheless, it has not
been reported whether human epidermal Langerhans
cells (LC) have histamine receptors or not. In this study,
using RT-PCR, we investigated the expression of H1
and H2 receptor mRNA on DC with the features of
LC (LC-like DC) that were generated in vitro from per-
ipheral blood monocytes, LC derived from CD34þ he-
matopoietic progenitor cells, and LC obtained from
human epidermis.We compared the histamine-induced
CD86 expression among these cells. In contrast to
MoDC, LC and LC-like DC did not express H1 or H2
receptors. In addition, they could not augment the
CD86 expression by histamine. Interestingly, when
transforming growth factor-b1 (TGF-b1) was added to
the culture of MoDC, the expression of H1 and H2 re-
ceptors and the histamine-induced CD86 expression
were abrogated in a concentration-dependent fashion.
Finally, in the assessment of the cell surface expression
of histamine receptors using £uorescence-labeled hista-
mine, histamine could bind to MoDC and dermal den-
dritic cells obtained from the skin, whereas there was
no speci¢c binding of histamine to LC-like DC or LC
obtained from the skin. These data suggest that LC do
not express either H1 or H2 receptors, mainly because
of the e¡ect of TGF-b1. This made a striking contrast
with the expression of the functional H1 and H2 recep-
tors on MoDC and dermal dendritic cells. Key words:
CD86/TGF-b. J Invest Dermatol 121:1073 ^1079, 2003
D
endritic cells (DC) comprise at least three distinct
subsets including two with a myeloid lineage and
a third represented by lymphoid DC (Caux et al,
1996, 1997; Rissoan et al, 1999). Langerhans cells
(LC) and interstitial DC constitute two types of
immature myeloid DC in vivo. In in vitro cultures of CD34þ he-
matopoietic progenitor cell (HPC) in granulocyte^macrophage
colony-stimulating factor (GM^CSF)/tumor necrosis factor (TNF)-
a-supplemented medium, CD14^CD1aþ LC precursors, and
CD14þCD1a^precursors, which apparently di¡er from each
other in their lineage commitment, emerge early during the cul-
ture. LC precursors give rise to CD1aþ E-cadherin (E-cad)þ Bir-
beck granuleþ but CD11b^CD36^ factor XIIIa LC, whereas
CD14þCD1a^ precursors di¡erentiate into macrophages/mono-
cytes and non-LC interstitial DC with the help of M^CSF and
GM^CSF/TNF-a, respectively (Caux et al, 1996, 1997). These in-
terstitial DC, which are characterized by the abundant expression
of factor XIIIa, CD1a, CD11b, and CD36 with the virtual absence
of E-cad and Birbeck granule, display striking similarities to
dermal DC (DDC) (Nestle et al, 1993; Caux et al, 1996, 1997; de
Saint-Vis et al, 1998). DC with the features of dermal DC were
also induced by the culture of peripheral blood monocytes with
GM^CSF and interleukin (IL)-4 (Romani et al, 1994; Sallusto and
Lanzavecchia, 1994).
In addition to these phenotypic di¡erences between LC and
DDC, it has become clear that the expression of C-type lectins
can clearly discriminate DDC from LC. Namely, Langerin is pre-
ferentially expressed by LC, whereas DC-SIGN and macrophage
mannose receptors are demonstrated only on DDC, which
strongly indicates the di¡erence in their immunologic roles (Tur-
ville et al, 2002).
Recently, Caron et al (2001a) have demonstrated that human
immature monocyte-derived dendritic cells (MoDC) have both
H1 and H2 receptors and that histamine induces CD86 expression
and chemokine production by MoDC, which can be blocked by
both H1 and H2 receptor antagonists. As we have already de-
scribed, LC do not necessarily share phenotypic and functional
characteristics with MoDC. Therefore, although H1 and H2 re-
ceptors are widely distributed in many tissues including the epi-
dermis (Greaves and Davies, 1982), it is not self-evident that
human epidermal LC have histamine receptors.
To address this question, in this study, we generated LC or LC-
like DC in vitro and isolated LC from human epidermis. For this
purpose, we generated LC from CD34þ HPC in the presence of
GM^CSF with a combination of TNF-a, stem cell factor (SCF),
transforming growth factor (TGF)-b1, and Flt3 ligand (Flt3L)
(Strobl et al, 1997; Gatti et al, 2000), in the presence of M^CSF,
TNF-a, SCF, TGF-b1, and Flt3L (Mollah et al, 2003) or LC-like
DC from peripheral blood monocytes with GM^CSF, IL-4, and
TGF-b1 (Geissmann et al, 1998) or with GM^CSF and IL-15
(Mohamadzadeh et al, 2001). Using these cells, we examined their
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expression of H1 and H2 receptors and their ability to augment
the CD86 expression by histamine stimulation. The results de-
monstrated that, in contrast to MoDC, human LC do not express
H1 and H2 receptors. Interestingly, we found that the expression
of H1 and H2 receptors on MoDCwas lost by addingTGF-b1. In
addition, we succeeded in demonstrating the cell surface expres-
sion of histamine receptors by MoDC as well as DDC recovered
from human dermis using £uorescence-labeled histamine.
Approval for all work was granted by the Ethics Committee of
Tohoku University Graduate School of Medicine, in accordance
to the declaration of Helsinki.
MATERIALS AND METHODS
Media and reagents The medium used in the study was RPMI
1640 including 25 mM HEPES bu¡er (Sigma Chemical Co., St. Louis,
MO) supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate,
1% penicillin, streptomycin, and fungizone antibiotic solution (Sigma)
and 10% fetal calf serum (Bioserum, Canterbury, Victoria, Australia)
(complete medium). Histamine dihydrochloride (Sigma) was used for the
stimulation of MoDC, LC, and LC-like DC. We used the following
monoclonal antibodies for immunostaining: £uorescein isothiocyanate
(FITC)- or phycoerythrin (PE)-conjugated anti-CD1a antibody (Immuno-
tech, Beckman Coulter Company, Marseille, France), PE-conjugated
anti-HLA-DR antibody (BD Biosciences, San Jose, CA), FITC-conjugated
anti-CD86 antibody (PharMingen, San Diego, CA), and anti-human
E-cad antibody (Takara Biomedicals, Tokyo, Japan) as well as FITC-
or PE-conjugated isotype-matched mouse control antibodies (IgG2a and
IgG1) (PharMingen). MACS colloidal supermagnetic microbeads conjugated
with anti-human CD14 monoclonal antibody (CD14 microbeads)
and those with anti-human CD1a monoclonal antibody (CD1a micro-
beads) were purchased from Miltenyi Biotec (Sunnyvale, CA). Recombi-
nant human GM^CSF was a gift from Kirin Brewery Co. (Tokyo,
Japan). Recombinant human IL-4, recombinant human IL-15, recombi-
nant human TGF-b1, recombinant human M^CSF, recombinant human
TNF-a, recombinant human SCF, and recombinant human Flt3L were
purchased from PeproTech (London, England). For the culture of LC
from CD34þ HPC, X-VIVO 15 medium (Bio-Whittaker, Walkersville,
MD) supplemented with SCF (20 ng/mL), Flt3L (100 ng/mL),TNF-a (2.5
ng/mL), and TGF-b1 (2.5 ng/mL) with GM^CSF (100 ng/mL) (GM^CSF
X-VIVO medium) or M^CSF (100 ng/mL) (M^CSF X-VIVO medium)
was used. Throughout the experiments, the amount of endotoxin in the
culture medium was o30 pg per mL as determined by the Limulus
amebocyte lysate assay (Seikagaku Co. Inc. Tokyo, Japan).
Culture of MoDC and LC-like DC from peripheral blood CD14þ
cells The culture of MoDC and LC-like DCwas performed according to
the methods described by Romani et al (1994), by Geissmann et al (1998),
and by Mohamadzadeh et al (2001). Brie£y, peripheral blood mononuclear
cells were isolated from heparinized fresh leukocyte-enriched bu¡y coats
from eight healthy Japanese volunteers (six men and two women, aged
from 18 to 29 years with a mean of 24 years) by discontinuous density
gradient centrifugation using Lymphoprep (Nycomed Pharma As, Oslo,
Norway). CD14þ monocytes were separated by a magnetic cell separator
using CD14 microbeads according to the manufacturer’s protocol. Before
culture, we examined the percentage of CD14þ cells in these pre-
parations by £ow cytometry, and in the following experiments we used
only the cell specimens containing more than 98% of CD14þ cells. To
induce MoDC, these CD14þ monocytes (2106/mL) were cultured in
complete medium containing GM^CSF (100 ng/mL) and IL-4 (100 ng/
mL) for 6 days (Romani et al, 1994). To induce LC-like DC, they (2106/
mL) were cultured in the same medium with various concentrations of
TGF-b1 (1, 10, and 100 ng/mL) (Geissmann et al, 1998) or in complete
medium containing 100 ng/mL GM^CSF and 200 ng/mL IL-15 for 6 days
(Mohamadzadeh et al, 2001). One-half of the culture medium was changed
on days 3 and 6. On day 7, MoDC and LC-like DC were examined for the
expression of H1 and H2 receptor mRNA, for their cell surface expression
of histamine receptors, and for their ability to respond to the optimal
concentration of histamine (10^5 M), which was determined previously
(Ohtani et al, 2003), by the augmentation of CD86 expression.
Culture of LC from CD34þ HPC Umbilical cord blood samples
were obtained according to institutional guidelines with signed, informed
consent provided by the donors. Cells bearing CD34 antigen were isolated
from mononuclear fractions of cord blood through positive selection as
described ( Jaksits et al, 1999; Mollah et al, 2002). Brie£y, mononuclear cells
were prepared using Lymphoprep. CD34þ HPC were isolated from them
using a direct CD34 progenitor cell isolation kit (Miltenyi Biotec)
according to the manufacturer’s protocol. LC were then generated by two
di¡erent methods: CD34þ HPC (1104/mL/well) were cultured in GM^
CSF X-VIVO medium for 7 to 10 days (GM^CSF culture) (Gatti et al,
2000) or cultured in M-CSF X-VIVO medium for 10 to 14 days (M^CSF
culture) (Mollah et al, 2003). In every experiment, we employed both
culture systems for the purpose of comparison. After being cultured, cells
were collected from both types of cultures by gentle pipetting, and clusters
of LC were separated from single cells as described by Gatti et al (2000) and
used as cluster-puri¢ed LC. The puri¢ed clusters were examined for the
expression of H1 and H2 receptor mRNA and were stimulated by 10^5 M
histamine.
Isolation of human epidermal LC Single-cell suspensions of human
epidermal cells were harvested from full-thickness skin specimens ob-
tained during plastic surgery after obtaining the patients’ informed
consent. These specimens were incubated with 0.5% trypsin (Difco
Laboratories, Detroit, MI) for 45 min at 371C. Epidermal sheets were
separated from the dermis and transferred into a petri dish containing
phosphate-bu¡ered saline (PBS) with 30% fetal calf serum and DNase
(Sigma). A crude epidermal cell suspension was made by mechanical
disruption and was ¢ltered through a 100 mm nylon mesh (Becton
Dickinson, Tokyo, Japan). After being washed, the crude epidermal cell
suspension was cultured in complete medium for 48 h or applied onto
Lymphoprep and centrifuged at 300 g for 15 min at room temperature to
purify CD1aþ cells. The interface cells were collected and washed three
times, and CD1aþ cells were separated by MACS using CD1a microbeads
according to the manufacturer’s protocol. This LC-enriched fraction was
treated or untreated with 10^5 M histamine for 24 h in the presence of
GM^CSF (100 ng/mL). These experiments were approved by the ethics
committee of Tohoku University Graduate School of Medicine, Sendai,
Japan.
Isolation of human DDC Human DDC were obtained by the
procedure reported by Nestle et al (1993). Brie£y, full-thickness skin
specimens obtained during plastic surgery after providing informed
consent were incubated with 0.3% Dispase type 2 (Godosyusei Co Inc.
Tokyo, Japan) overnight at 41C. After the incubation period, the
epidermis and dermis could be easily separated. Dermal sheets were then
rinsed several times in PBS, cut into small pieces, and placed epidermal
side up in complete medium in a 10-cm tissue culture plate. After 3 days,
the cells migrating out of the cultured dermis into the medium were used
to analyze the cell surface expression of histamine receptors. This
experiment was also approved by the ethics committee of Tohoku
University Graduate School of Medicine, Sendai, Japan.
Flow cytometry Cells were incubated with FITC-conjugated mono-
clonal antibodies as well as isotype control monoclonal antibodies (10 mg/
mL) in PBS supplemented with 1% bovine serum albumin and 0.02%
NaN3 (washing bu¡er). After being washed, the cells were analyzed
by FACScan using CellQuest software (Becton Dickinson). Dead
cells were gated out by adding 0.5 mg per mL propidium iodide solution.
For E-cad expression, the cells were ¢rst incubated with anti-E-
cad antibody or isotype-matched control antibody and reacted with
PE-conjugated anti-mouse immunoglobulins (Tago Immunologicals,
Camarillo, CA).
Assessment of the cell surface expression of histamine receptors
on MoDC, LC-like DC, and DDC MoDC, LC-like DC, cultured
epidermal cell suspensions, or DDC were used to analyze their cell surface
expression of histamine receptors following a published protocol (Harris
and Hutchinson, 1994). In brief, cells were incubated for 30 min on ice
with BODIPY FL-histamine (10^5 M, Molecular Probes, Eugene, OR)
and analyzed by £ow cytometry. In some experiments, cells were also
incubated for 30 min with histamine (10^4 M); olopatadine (10^4 M,
Kyowa Hakko Kogyo Co., Ltd. Tokyo, Japan), a potent H1 antagonist
(Ohtani et al, 2003); cimeditine (10^3 M, Sumitomo Pharmaceuticals Co.,
Ltd. Osaka, Japan); or PBS to demonstrate speci¢c binding. To examine
histamine binding to epidermal cell suspensions or DDC, the cells were
also stained with PE-conjugated anti-CD1a or anti-HLA-DR antibody,
and then histamine binding was demonstrated on the CD1aþ or HLA-
DRþ cell population. Dead cells were gated out by adding 0.5 mg per mL
propidium iodide solution.
Detection of mRNA by RT-PCR analysis Total RNAwas extracted
by the guanidinium thiocyanate method described by the manufacturer
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(Isogen, Nippon Gene Inc.,Toyama, Japan) from MoDC, LC-like DC, and
LC. cDNAwas obtained from total RNA using aTaKaRa RNA PCR kit
(AMV) (Takara Biochemicals, Osaka, Japan) according to the
manufacturer’s protocol. The following primers designed using Primer
Express version 1.0 (PE Applied Biosystems, Foster City, CA) were
produced by Nippon gene Inc. (Toyama, Japan) for PCR ampli¢cation:
H1 receptor (318-bp product), sense 50 -GAC TGT GTA GCC GTC AAC
CGG A-30 and antisense 50 -TGA AGG CTG CCATGATAA AAC C-30;
and H2 receptor (332-bp product), sense 50 -TCG TGT CCT TGG CTA
TCA C-30 and antisense 50 -CCT TGC TGG TCT CGT TCC T-30.
RNA integrity and cDNA synthesis were veri¢ed by amplifying
GAPDH cDNA. After an initial denaturation step at 941C for 3 min, 35
PCR cycles were run at 941C (denaturation, 30 s), 571C (annealing, 30 s),
and 721C (extension, 30 s). PCR products were subjected to electrophoresis
on a 1.5% agarose gel and visualized by means of ethidium bromide staining.
RESULTS
The lack of functional H1 and H2 receptors in LC-like DC
derived from peripheral blood monocytes At ¢rst, we con-
¢rmed that MoDC express H1 and H2 receptors, which can
induce CD86 expression after histamine stimulation (Fig 1), as
reported by Caron et al (2001b). When we ampli¢ed cDNA
derived from the RNA of MoDC using speci¢c primers for H1
and H2 receptor mRNA, MoDC expressed PCR products
corresponding to cDNA for H1 and H2 receptors, respectively,
the expected molecular sizes of which were 318 and 332 bp in
length, respectively. To further corroborate the expression of
histamine receptors on MoDC, we examined whether BODIPY
FL-histamine could bind to MoDC. By the comparison with the
histogram of MoDC pre-treated with an excess amount of
nonlabeled histamine or anti-H1 and/or H2 histamines, it
became clear that the binding of BODIPY FL-histamine to
MoDC was at least in part speci¢c (Fig 2). In addition, the £ow
cytometric analysis demonstrated that MoDC treated with
10^5 M histamine for 24 h had augmented CD86 expression
(Fig 3a).
To examine the expression of H1 and H2 receptors on LC, at
¢rst, we examined the expression of mRNA for H1 and H2
receptors on LC-like DC derived from monocytes (Fig 1). In
contrast to PCR products ampli¢ed from cDNA of MoDC,
those from LC-like DC that were obtained by the culture of
monocytes with GM^CSF, IL-4, and TGF-b1 or that with GM^
CSF and IL-15 did not demonstrate the bands corresponding to
the H1 or H2 receptor. Consistent with the lack of mRNA
for H1 and H2 receptors, the speci¢c binding of BODIPY
FL-histamine, which could be blocked by an excess amount
of nonlabeled histamine or the antihistamines, was not
demonstrated on LC-like DC (Fig 2). When we examined the
augmentation of CD86 expression by LC-like DC induced by
GM^CSF, IL-4, and TGF-b1, it became clear that TGF-b1
suppressed the augmentation of CD86 expression stimulated
with histamine, whereas it increased the expression of E-cad by
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1. GM-CSF + IL-4
5. GM-CSF + IL-15
6. GM-CSF + TNF-α + SCF + FIt3-L + TGF-β1
7. M-CSF + TNF-α + SCF + FIt3-L + TGF-β1
2. GM-CSF + IL-4 + TGF-β1 (1 ng/ml)
3. GM-CSF + IL-4 + TGF-β1 (10 ng/ml)
4. GM-CSF + IL-4 + TGF-β1 (100 ng/ml)
derived from monocytes
derived from HPCs
Figure1. Expression of mRNA for histamine H1 and H2 receptors
by MoDC, LC-like DC derived from monocytes, and LC derived
from CD34þ HPC. MoDC, two di¡erent LC-like DC, and LC were
induced from peripheral blood monocytes or CD34þHPC as described
under Materials and Methods.Total RNAwas extracted by the guanidinium
thiocyanate method from these cells and reverse-transcribed. After ampli-
¢cation, PCR products were subjected to electrophoresis and visualized by
means of ethidium bromide staining. MoDC (lane 1), MoDC with 1 ng per
mL TGF-b1 (lane 2), MoDC with 10 ng per mL TGF-b1 (lane 3), MoDC
with 100 ng per mL TGF-b1 (lane 4), LC-like DC induced by GM^CSF
and IL-15 (lane 5), LC derived from HPC by GM^CSFþTNF-
aþFlt3LþSCFþTGF-b1 (lane 6), and LC derived from HPC by
M-CSFþTNF-aþFlt3LþSCFþTGF-b1 (lane 7). These are representative
data of three independent experiments.
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Figure 2. Binding of BODIPY FL-histamine on MoDC and LC-like DC. MoDC (a) or LC-like DC (b) were obtained from CD14þ monocytes
cultured in complete medium containing GM^CSF and IL-4 with or without TGF-b1 for 6 days, respectively. Cells were incubated for 30 min on ice with
BODIPY FL-histamine (10^5 M) and analyzed by means of £ow cytometry. Some of the cells were preincubated for 30 min with histamine (10^4 M),
olopatadine (10^4 M), cimeditine (10^3 M), or both olopatadine and cimetidine to demonstrate the speci¢c binding.
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MoDC in a concentration-dependent fashion (Fig 3a). Similarly,
LC-like DC induced by GM^CSF and IL-15 did not augment
the CD86 expression by histamine (Fig 3b).
The lack of functional H1 and H2 receptors in LC derived
from CD34þ HPC Next, we examined the expression of H1
and H2 receptors on LC derived from HPC. Again LC derived
either from the culture of HPC with GM^CSF, TNF-a, FLt3L,
SCF, and TGF-b1 or from that with M^CSF, TNF-a, FLt3L,
SCF, and TGF-b1 did not contain PCR products corresponding
to mRNA for the H1 or H2 receptor (Fig 1). The £ow cytometric
analysis also demonstrated their lack of ability to augment the
CD86 expression by histamine stimulation (Fig 3b).
The lack of functional H1 and H2 receptors in LC derived
from the epidermis Finally, we examined the expression of
H1 and H2 receptors by LC obtained from human epidermis.
Because keratinocytes express both H1 and H2 receptors, and it
is impossible to obtain pure epidermal LC, we prepared three
epidermal cell populations, including a crude epidermal cell
suspension, an LC-enriched fraction that contained approxi-
mately 90% LC (Fig 4a), and a keratinocyte suspension that was
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Figure 3. LC-like DC derived from monocytes and LC derived from HPC lack the ability to augment CD86 expression by histamine
stimulation. (a) MoDC and MoDC treated with di¡erent concentrations of TGF-b1, were treated with histamine for 24 h. The surface expression of
CD1a, CD86, and E-cad by these cells was examined by £ow cytometry. (b) LC-like DC induced by GM^CSF and IL-15; LC derived from HPC by
GM^CSFþTNF-aþFlt3LþSCFþTGF-b1; and LC derived from HPC by M-CSFþTNF-aþFlt3LþSCFþTGF-b1 were treated with histamine for 24 h.
The surface expression of CD86 by CD1aþ cells was examined by £ow cytometry.This is a representative £ow cytometry of three independent experiments.
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obtained from the crude epidermal cell suspension by depleting
LC.The PCR analysis demonstrated that the crude epidermal cell
suspension and keratinocyte suspension expressed both H1 and
H2 receptor mRNA with a slightly augmented expression by
the keratinocyte suspension. In contrast, the LC-enriched
fraction showed only a faint band corresponding to the H1
receptor, but not that corresponding to the H2 receptor
(Fig 4b). Considering that the LC-enriched fraction was still
contaminated with 10% keratinocytes, we regarded the faint
band for the H1 receptor as having originated from the
contaminating RNA of keratinocytes. Consistent with these
data, the binding of BODIPY FL-histamine to CD1aþ cells in
the epidermal cell suspensions was not suppressed by the excess
amount of histamine (Fig 5). Again, the LC-enriched fraction
did not show augmented CD86 expression by histamine
stimulation (Fig 4c).
Expression of histamine receptor on DDC Because these
data revealed that the expression of histamine receptors was
quite speci¢c to MoDC, we determined whether this was not a
simple in vitro phenomenon rather something that can occur on
DDC obtained from the skin, which are regarded as an in vivo
counterpart of MoDC. For this purpose, again we examined the
binding of BODIPY FL-histamine to CD1aþ or HLA-DRþ
cells among the cells migrating out of the organ cultured
dermis. The results demonstrated that BODIPY FL-histamine
bound to either CD1aþ or HLA-DRþ cells, which was
signi¢cantly blocked by an excess amount of histamine,
suggesting that the binding was speci¢c (Fig 6).
DISCUSSION
This study succeeded in clearly demonstrating the lack of mRNA
for H1 and H2 receptors in LC and that of their cell surface ex-
pression. In contrast, we succeeded in showing the cell surface
expression of histamine receptors by human DDC obtained from
the skin.This report directly demonstrates histamine receptors on
DDC.These data indicated a striking di¡erence in the response to
histamine between LC and non-LC DC including MoDC and
interstitial/dermal DC. Only DDC but not LC are in£uenced by
histamine released by mast cells. Because Sueki et al (1993) re-
ported the close association of some subpopulation of DDC with
mast cells, it is suggested that the functions of DDC are tightly
regulated by mast cells via histamine.
The e¡ects of histamine on MoDC so far reported are
summarized as follows: (1) the upregulation of CD86; (2) the in-
duction of a potent production of IL-6, IL-8, monocyte che-
moattractant protein 1, and macrophage-in£ammatory protein
1a (Caron et al, 2001b); (3) the inhibition of lipopolysaccharide-
induced IL-12p70 production; (4) the augmentation of lipopoly-
saccharide-induced IL-10 production; and (5) the polarization of
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Figure 4. LC obtained from the skin lack mRNA for histamine H1 and H2 receptors and the ability to induce CD86 expression by histamine
stimulation. (a) The purity of epidermal LC isolated from human skin. Single-cell suspensions of human epidermal cells were obtained by trypsinization
of full-thickness skin specimens.They were applied onto Lymphoprep and centrifuged, and the interface cells were collected. CD1aþcells were separated by
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epidermal cell suspension by depleting LC (lane 3). (c) The expression of CD86 by epidermal LC stimulated with histamine. LC-enriched fraction was
cultured with or without histamine in the presence of GM^CSF for 24 h and examined for the expression of CD86 by £ow cytometry. This is a represen-
tative data of three independent experiments.
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Figure 5. Binding of BODIPY FL-histamine on LC obtained from
the skin.The epidermal cell suspension was cultured in complete medium
for 48 h, and nonadherent cell were recovered for the analysis. Cells were
pre-incubated for 30 min on ice with BODIPY FL-histamine (10^5 M) and
PE-conjugated anti-CD1a antibody and analyzed by £ow cytometry. Some
of the cells were incubated for 30 min with histamine (10^4 M) to demon-
strate the speci¢c binding. Dead cells were gated out by adding 0.5 mg per
mL propidium iodide solution. These are representative data of two inde-
pendent experiments.
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MoDC into Th2 cell-promoting e¡ector DC (Caron et al, 2001a;
Mazzoni et al, 2001; Gutzmer et al, 2002; Idzko et al, 2002).
Among these e¡ects, the inhibition of IL-12p70 production by
DDC in the presence of a maturation signal seems to be the
most clinically relevant phenomenon. In atopic dermatitis, it is
conceivable that there is a positive feed back loop in which Th2
cells favor IgE production, leading to increased production of
histamine secretion by mast cells, which polarizes DDC into
Th2 cell-promoting e¡ector DC.
In this study, we used BODIPY FL-histamine to demonstrate
the speci¢c binding of histamine on the cell surface. When we
examined its binding on a variety of DC, we recognized its un-
predictable nonspeci¢c binding, which was not suppressed by
either an excess amount of nonlabeled histamine or histamine an-
tagonists. In most cases, MoDC and LC-like DC demonstrated
high and uniform nonspeci¢c bindings, whereas the nonspeci¢c
binding to DDC was negligible. Surprisingly, the histogram of
the binding of BODIPYs FL-histamine to LC obtained from
the skin made two peaks. Because even the bright peak was not
diminished by the excess amount of nonlabeled histamine, we
concluded that histamine did not bind to these LC via speci¢c
histamine receptors. Nevertheless, it remains unclear whether
LC are composed of two populations in terms of the nonspeci¢c
binding of histamine.
Next, we also demonstrated that even 1 ng per mL TGF-b1
signi¢cantly suppressed the expression of mRNA for both H1
and H2 receptors by MoDC and downregulated their augmenta-
tion of CD86 expression by histamine stimulation. Several recent
studies have identi¢edTGF-b as a mandatory factor for the devel-
opment of LC, but not for that of interstitial/dermal DC, both
in vivo (Borkowski et al, 1997) and in vitro (Strobl et al, 1996; Riedl
et al, 1997; Strobl et al, 1997; Geissmann et al, 1998; Caux et al, 1999).
Therefore, there seems to be a reciprocal relationship between the
di¡erentiation of DC toward LC and their expression of hista-
mine receptors, which is mainly induced by the e¡ects of TGF-
b. Interestingly, however, in our study, this reciprocal relationship
was recognized on even LC-like DC induced by GM^CSF and
IL-15. Because it was demonstrated that the elimination of endo-
genous serumTGF-b1 by adding neutralizing anti-TGF-b1 anti-
body during the induction of LC-like DC with GM^CSF and
IL-15 did not inhibit the induction of the LC phenotype (Moha-
madzadeh et al, 2001),TGF-b1might not be solely responsible for
the loss of histamine receptors on LC.
H1 and H2 receptors are well known to be expressed in a vari-
ety of cells, including keratinocytes, endothelial cells, smooth
muscle cells, and glial cells (reviewed in Simmons, 1998). To our
knowledge, however, no report has examined the e¡ects of TGF-
b1 on the expression of H1 and H2 receptors on these cells. So, at
present, we cannot conclude whether the e¡ect of TGF-b1 on H1
and H2 receptors we demonstrated is a phenomenon restricted to
MoDC or can be observed in other H1 or H2 receptor-expressing
cells. This is under current investigation.
This study was supported in part by Grant 14657198 from the Ministry of Education,
Science and Culture of Japan and by Japan Chemical IndustryAssociation (the long-
range research initiative).
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